Testing Aims to Personalize Treatment, Predict Transplant Outcomes in Cholangiocarcinoma
Published: Wednesday, Oct 02, 2019
Lewis R. Roberts, MB, ChB, PhD
A regimen of chemotherapy, radiation, and transplant has shown promise in the perihilar and intrahepatic subgroups of cholangiocarcinoma, said Lewis R. Roberts, MB, ChB, PhD, adding that personalized approaches are on the horizon to identify patients who will best respond to this approach.
... to read the full story